(NP (NP (NN Mineralocorticoid) (NN effector) (NN mechanism)) (PP (IN in) (NP (NN preeclampsia))) (. .))
(S (NP-SBJ-36 (NN Mineralocorticoid) (NN effector) (NNS mechanisms)) (VP (VBD were) (VP (VBN evaluated) (NP (-NONE- *-36)) (PP-COOD (PP (IN in) (NP (NP (CD 29) (NNS patients)) (PP (IN with) (NP (NN preeclampsia))))) (CC and) (PP (IN in) (NP (CD 25) (JJ uncomplicated) (NNS pregnancies)))) (PP (IN by) (NP (NP (NN measurement)) (PP (IN of) (NP-COOD (NP (NN plasma) (NN aldosterone)) (, ,) (NP (NP (NNS levels)) (PP (IN of) (NP (NP (NP (NN mineralocorticoid) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN MR)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ mononuclear) (NNS leucocytes)))))) (, ,) (CC and) (NP (NP (NN subtraction) (NN potential) (NN difference)) (PRN (-LRB- -LRB-) (NP (NN SPD)) (: ;) (NP (ADJP-COOD (ADJP (JJ rectal)) (CC minus) (ADJP (JJ oral))) (NNS values)) (-RRB- -RRB-))))))))) (. .))
(S-COOD (S (NP-SBJ (NP (NN Mean) (NNS values)) (PP (IN for) (NP (NN plasma) (NN aldosterone)))) (VP (VBD were) (RB not) (ADJP-PRD (JJ different)) (PP (IN between) (NP (DT the) (CD two) (NNS groups))))) (, ,) (CC but) (S (NP-SBJ-37 (JJ significant) (NNS differences)) (VP (VBD were) (VP (VBN observed) (NP (-NONE- *-37)) (PP (IN for) (NP-COOD (NP (NP (NN MR)) (PRN (-LRB- -LRB-) (NP-COOD (NP (NP (NN preeclampsia)) (, ,) (NP (QP (CD 81) (CC (- +)) (CD 44)) (NNS (cell receptors)))) (: ;) (NP (NP (NNS controls)) (, ,) (NP (QP (CD 306) (CC (- +)) (CD 168))))) (-RRB- -RRB-))) (CC and) (NP (NN SPD) (PRN (-LRB- -LRB-) (NP-COOD (NP (NP (NN preeclampsia)) (, ,) (NP (QP (CD 65) (CC (- +)) (CD 7)) (NN mV))) (: ;) (NP (NP (NNS controls)) (, ,) (NP (QP (CD 12) (CC (- +)) (CD 5)) (NN mV)))) (-RRB- -RRB-)))))))) (. .))
(S (PP (IN In) (NP (CD six) (NNS cases))) (NP-SBJ (PRP we)) (VP (VBD determined) (NP (NP-COOD (NP (NN MR)) (, ,) (NP (NN plasma) (NN aldosterone)) (, ,) (CC and) (NP (NN SPD))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN preeclampsia))) (PP-TMP (PP-COOD (PP (IN before) (NP (-NONE- *RNR*-38))) (CC and) (PP (NP (CD 3) (NNS months)) (IN after) (NP (-NONE- *RNR*-38)))) (NP-38 (NN delivery))))))) (. .))
(S (S-COOD (S (NP-SBJ-39 (NNS MR)) (VP (VBD were) (VP (VP (VBN reduced) (NP (-NONE- *-39)) (PP-TMP (IN before) (NP (NN delivery)))) (PRN (-LRB- -LRB-) (NP (QP (CD 96) (CC (- +)) (CD 27)) (NNS (cell receptors))) (-RRB- -RRB-))))) (, ,) (CC and) (S (NP-SBJ (NN SPD)) (VP (VP (VBD increased)) (PRN (-LRB- -LRB-) (NP (QP (CD 64) (CC (- +)) (CD 8)) (NN mV)) (-RRB- -RRB-))))) (, ,) (PP (IN with) (S (NP-SBJ (DT both) (NNS parameters)) (VP (VP (VBG normalizing) (PP-TMP (IN after) (NP (NN delivery)))) (PRN (-LRB- -LRB-) (NP-COOD (NP (NP (NN MR)) (, ,) (NP (QP (CD 242) (CC (- +)) (CD 79)))) (: ;) (NP (NP (NN SPD)) (, ,) (NP (QP (CD 14.0) (CC (- +)) (CD 4)) (NN mV)))) (-RRB- -RRB-))))) (. .))
(S (NP-SBJ (NN Aldosterone) (NNS levels)) (VP (VBD returned) (PP (TO to) (NP (JJ normal) (JJ nonpregnant) (NNS values))) (PP-TMP (IN after) (NP (NN delivery)))) (. .))
(S (NP-SBJ (DT These) (NNS data)) (VP-COOD (VP (VBP suggest) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN for) (NP (NP (NNS abnormalities)) (PP (IN in) (NP (NN mineralocorticoid) (NN effector) (NNS mechanisms))))) (PP (IN in) (NP (NP (DT the) (NN etiology)) (PP (IN of) (NP (NN preeclampsia))))))) (CC and) (VP (MD could) (VP (VB be) (NP-PRD (NP (DT an) (JJ useful) (NN marker)) (PP (IN for) (NP (NN diagnosis))))))) (. .))
